17-alpha-hydroxyprogesterone has been researched along with Infant, Premature, Diseases in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (23.08) | 18.7374 |
1990's | 2 (15.38) | 18.2507 |
2000's | 5 (38.46) | 29.6817 |
2010's | 3 (23.08) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, YS; Kim, JW; Lee, SY; Oh, HJ; Park, HD; Park, WS; Seo, JY; Yang, JS | 1 |
Cheillan, D; Godefroy, A; Huet, F; Roussey, M; Somma, C | 1 |
Choi, JW; Jun, YH; Lee, JE; Lee, MH; Moon, Y; Oh, KI | 1 |
Couch, R; Girgis, R | 1 |
Bartoshesky, L; Leef, KH; Paul, DA; Stefano, JL | 1 |
Martins, PG; Procianoy, RS | 1 |
Dyas, J; Hughes, IA; Joyce, BG; Murphy, JF | 1 |
Azmy, BS; Khalid, BA; Lo, MS; Ng, ML; Wu, LL | 1 |
Khalid, BA; Lo, MS; Ng, ML; Wu, LL | 1 |
De Ridder, MA; Hokken-Koelega, AC; Huysman, MW; Sauer, PJ | 1 |
Hagenfeldt, L; Larsson, A; Marcus, C; Nordenström, A; Wedell, A | 1 |
Dyas, J; Hughes, D; Hughes, IA; Murphy, JF; Riad-Fahmy, D; Robinson, JA | 1 |
Berry, J; Betts, P; Wood, PJ | 1 |
1 trial(s) available for 17-alpha-hydroxyprogesterone and Infant, Premature, Diseases
Article | Year |
---|---|
Steroid profiling for congenital adrenal hyperplasia by tandem mass spectrometry as a second-tier test reduces follow-up burdens in a tertiary care hospital: a retrospective and prospective evaluation.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Androstenedione; Biomarkers; Chromatography, Liquid; Dried Blood Spot Testing; False Positive Reactions; Follow-Up Studies; Humans; Hydrocortisone; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Neonatal Screening; Predictive Value of Tests; Prospective Studies; Retrospective Studies; Tandem Mass Spectrometry; Tertiary Care Centers | 2014 |
12 other study(ies) available for 17-alpha-hydroxyprogesterone and Infant, Premature, Diseases
Article | Year |
---|---|
[Do we need congenital adrenal hyperplasia screening for premature infants?].
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Cross-Sectional Studies; France; Gestational Age; Humans; Infant, Extremely Low Birth Weight; Infant, Newborn; Infant, Premature, Diseases; Neonatal Screening; Pilot Projects; Predictive Value of Tests; Unnecessary Procedures | 2014 |
Corrected 17-alpha-hydroxyprogesterone values adjusted by a scoring system for screening congenital adrenal hyperplasia in premature infants.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Birth Weight; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Reference Values; Treatment Outcome | 2008 |
Postnatal virilization mimicking 21-hydroxylase deficiency in 3 very premature infants.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Diagnosis, Differential; Female; Humans; Infant, Extremely Low Birth Weight; Infant, Newborn; Infant, Premature, Diseases; Testosterone; Virilism | 2012 |
Factors influencing levels of 17-hydroxyprogesterone in very low birth weight infants and the relationship to death and IVH.
Topics: 17-alpha-Hydroxyprogesterone; Cohort Studies; Female; Gestational Age; Humans; Infant Mortality; Infant, Newborn; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Intracranial Hemorrhages; Logistic Models; Male; Neonatal Screening | 2004 |
Cortisol and 17-alpha-hydroxy-progesterone levels in infants with refractory hypotension born at 30 weeks of gestation or less.
Topics: 17-alpha-Hydroxyprogesterone; Biomarkers; Case-Control Studies; Gestational Age; Humans; Hydrocortisone; Hypotension; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Prospective Studies; Time Factors | 2007 |
Plasma 17-hydroxyprogesterone concentrations in ill newborn infants.
Topics: 17-alpha-Hydroxyprogesterone; Birth Weight; Gestational Age; Humans; Hydroxyprogesterones; Infant, Low Birth Weight; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature, Diseases | 1983 |
Usefulness and limitations of an in-house direct radioimmunoassay for 17-hydroxyprogesterone in serum.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Hyperplasia, Congenital; Adult; Animals; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Middle Aged; Pregnancy; Rabbits; Radioimmunoassay; Reproducibility of Results; Sensitivity and Specificity | 1996 |
Measurement of androstenedione levels by an in-house radioimmunoassay.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Hyperplasia, Congenital; Adult; Androstenedione; Child; Child, Preschool; Circadian Rhythm; Female; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Middle Aged; Pregnancy; Puberty; Radioimmunoassay; Reference Values; Reproducibility of Results; Sensitivity and Specificity | 1996 |
Adrenal function in sick very preterm infants.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Glands; Adrenocorticotropic Hormone; Bronchopulmonary Dysplasia; Female; Humans; Hydrocortisone; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Prognosis; Respiration, Artificial | 2000 |
Neonatal screening for congenital adrenal hyperplasia: 17-hydroxyprogesterone levels and CYP21 genotypes in preterm infants.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Gene Deletion; Genotype; Humans; Infant, Newborn; Infant, Premature, Diseases; Mutation; Neonatal Screening; Radioimmunoassay; Steroid 21-Hydroxylase | 2001 |
Blood spot glucocorticoid concentrations in ill preterm infants.
Topics: 17-alpha-Hydroxyprogesterone; Aging; Blood Specimen Collection; Female; Humans; Hydrocortisone; Hydroxyprogesterones; Infant, Newborn; Infant, Premature, Diseases; Longitudinal Studies; Male; Stress, Physiological | 1987 |
The interpretation of bloodspot 17 alpha-hydroxyprogesterone levels in term and pre-term neonates.
Topics: 17-alpha-Hydroxyprogesterone; Humans; Hydrocortisone; Hydroxyprogesterones; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Sodium | 1986 |